Photo: RNZ // Angus Dreaver
An urgent legal injunction has been filed to stop the incoming ban on new prescriptions of puberty blockers to treat gender dysphoria.
Cabinet agreed last month to the new settings until a major clinical trial in the United Kingdom ends in 2031.
The drugs - known as gonadotropin-releasing hormone analogues - would remain available for people already using them.
The Professional Association for Transgender Health Aotear
Continue Reading on RNZ
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.